Kemar E. Green, DO, FANA
Kemar E. Green, DO, FANA, is a rare and complex disease neurologist with subspecialty expertise in neuro-opthalmology and neuro-otology. He is the founder and CEO of NeuroAgent AI, Inc. and HazyEyes, Inc., leading the development of AI-driven, autonomous neurodiagnostic and monitoring platforms. He remains affiliate faculty at the Johns Hopkins Data Science & AI Institute (DSAI), serves as a clinical mentor for Johns Hopkins Biomedical Engineering Undergraduate Design and Precision Care Medicine Design teams, and is a fellow of the American Neurological Association.
Michael Rosario-Prieto, MD
Michael Rosario-Prieto, MD, is a neuromuscular specialist at BayCare Neurology Group, the medical director for the Tampa Bay Muscular Dystrophy Care Center, and the team neurologist for the Tampa Bay Rays. He completed his medical training at New York Medical College and a neurology residency at University of Connecticut in 2012, where his interest in neuromuscular diseases was seeded. After fellowships at Duke University, he moved to Florida, where he has been treating patients and active in clinical trials for over a decade.
Tuan Vu, MD
Tuan Vu, MD, is a professor of neurology and the director of the Neuromuscular Division and Electromyography Laboratories at the University of South Florida Morsani College of Medicine. In addition to providing expert care to patients with neuromuscular diseases for more than 30 years and teaching neurophysiology and neuromuscular medicine, Dr. Vu is extensively involved in MG clinical trials and has also participated in numerous AlS, CIDP, and myositis/myopathy trials.
Sarah Wright, DO
Sarah Wright, DO, serves as the neuromuscular program director at Children’s National Hospital in Washington, D.C., where she cares for children and young adults with both hereditary and acquired nerve and muscle disorders. Dr. Wright’s research interests include novel therapeutic targets for Duchenne muscular dystrophy and juvenile myasthenia gravis.